Hydatidiform Mole: Clinical Trials

2 trials for Hydatidiform Mole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Recruiting 1

Follow Hydatidiform Mole: new trials by email Literature Review of Hydatidiform Mole trials Research Report on Hydatidiform Mole

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia
Methotrexate, Leucovorin, Dactinomycin - Gestational Trophoblastic Tumor, Gestational Trophoblastic Neoplasia
Not applicableActive not recruitingxiang yang2282020-09-292025-08-11
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
Follow up, chemotherapy - Hydatidiform Mole, Gestational Trophoblastic Neoplasia
Not applicableRecruitingWomen's Hospital School Of Medicine Zhejiang University302018-12-242026-03-16

Narrower conditions

Gestational Trophoblastic Disease (2)  ·  Choriocarcinoma (1)  ·  Hydatidiform Mole, Invasive (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Pregnancy Complications (2)  ·  Pregnancy Complications, Neoplastic (2)  ·  Trophoblastic Neoplasms (2)  ·  Urogenital Diseases (2)  ·  Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

Methotrexate (2)  ·  Dactinomycin (1)  ·  Drug Therapy (1)  ·  Leucovorin (1)

Sponsors

Women's Hospital School Of Medicine Zhejiang University (1)  ·  xiang yang (1)

Countries

China (2)

Top investigators

Xing Xie (1)

Results publications

PMID 37612621, PMID 40382972, PMID 40543844